ArticlePloS one2025
Adaptation of finnish diabetes risk score for screening undiagnosed diabetes and hyperglycemia in Chinese adults.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveChina has the largest population with diabetes globally, with over half of the cases going undiagnosed, highlighting the need for improved screening efforts. This study aimed to adapt the Finnish Diabetes Risk Score (FINDRSC), a widely used tool for assessing diabetes risk without relying on clinical indicators, for screening undiagnosed hyperglycemia and diabetes among Chinese adults.
methodsData from the China Health and Nutrition Survey (CHNS), collected in the 2009 wave, were utilized as the training data (n = 7277), and data from the Guangzhou Nutrition and Health Study (GNHS, n = 2970), conducted in the years 2011-2014, were used for validation. Diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or glycated hemoglobin A1c (HbA1c) ≥ 6.5%. Hyperglycemia was defined as FPG ≥ 5.6 mmol/L and/or HbA1c ≥ 5.7%. Predictors in the original FINDRISC model were adjusted according to local standards and guidelines to develop the Modified Chinese screening model (ModChinese). Coefficients and scores of the ModChinese model were estimated using logistic regression. Area under the receiver operating characteristic curve (AUC) was calculated to evaluate model performance.
resultsThe prevalence of undiagnosed diabetes and prediabetes was 8.6% and 40.1% in CHNS, and 3.1% and 27.9% in GNHS, respectively. The ModChinese demonstrated superior performance compared to the original FINDRISC, with higher AUC values for detecting both diabetes (0.707 vs. 0.681, p = 0.001) and hyperglycemia (0.680 vs. 0.661, p < 0.001) in the CHNS. Similar improvements were observed in the GNHS, where the ModChinese achieved AUC values of 0.663 for diabetes and 0.606 for hyperglycemia, compared to FINDRISC's 0.622 and 0.593, respectively. Compared with the original FINDRISC, the ModChinese model showed improved sensitivity and specificity for screening undiagnosed diabetes and enhanced sensitivity for hyperglycemia screening in both training and validation datasets.
conclusionThe ModChinese model is a simple and effective screening tool for identifying undiagnosed diabetes and hyperglycemia in Chinese adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.